Literature DB >> 8570378

Placebo washout is not a meaningful part of antidepressant drug trials.

R P Greenberg1, S Fisher, J A Riter.   

Abstract

Most trials testing the effectiveness of psychotropic drugs begin with a placebo washout phase. Hypothetically this technique rids studies of placebo responders before randomization of subjects to drug and placebo groups. In theory, this lowers the level of response to placebo in the study and magnifies the superiority of the response to medication. An analysis of 10 years of research literature demonstrates that the washout technique does not do what it was designed to do in antidepressant studies. Within placebo or drug groups neither measures of depression nor dropouts were affected by including a preliminary washout in the design. The findings are consistent with the two other studies that have addressed this issue.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8570378     DOI: 10.1177/003151259508100264

Source DB:  PubMed          Journal:  Percept Mot Skills        ISSN: 0031-5125


  5 in total

Review 1.  Meta-Analysis of Placebo Response in Adult Antidepressant Trials.

Authors:  Fenghua Li; Madeeha Nasir; Baris Olten; Michael H Bloch
Journal:  CNS Drugs       Date:  2019-10       Impact factor: 5.749

2.  Advancing the understanding of placebo effects in psychological outcomes of exercise: Lessons learned and future directions.

Authors:  Jacob B Lindheimer; Attila Szabo; John S Raglin; Chris Beedie
Journal:  Eur J Sport Sci       Date:  2019-07-09       Impact factor: 4.050

Review 3.  Mechanisms of the placebo effect in pain and psychiatric disorders.

Authors:  R D Holmes; A K Tiwari; J L Kennedy
Journal:  Pharmacogenomics J       Date:  2016-03-22       Impact factor: 3.550

4.  Randomized clinical trials with run-in periods: frequency, characteristics and reporting.

Authors:  David Ruben Teindl Laursen; Asger Sand Paludan-Müller; Asbjørn Hróbjartsson
Journal:  Clin Epidemiol       Date:  2019-02-11       Impact factor: 4.790

Review 5.  Run-in periods and clinical outcomes of antipsychotics in dementia: A meta-epidemiological study of placebo-controlled trials.

Authors:  Tessa A Hulshof; Sytse U Zuidema; Christine C Gispen-de Wied; Hendrika J Luijendijk
Journal:  Pharmacoepidemiol Drug Saf       Date:  2019-11-15       Impact factor: 2.890

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.